申请人:Rhizen Pharmaceuticals SA
公开号:US20140080827A1
公开(公告)日:2014-03-20
The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
本发明提供了PI3K蛋白激酶调节剂,其制备方法,包含它们的药物组合物以及使用它们治疗、预防和/或改善激酶介导的疾病或疾病的方法。